John Bransby is a Certified ReCODE Coach with Apollo Health, specialising in helping people with early-stage dementia to reverse their cognitive decline. John and I dissected the just-published Alzheimer's disease trial led by Dr Dean Ornish, that demonstrated improvement in cognitive function and Alzheimer's biomarkers in people diagnosed with mild cognitive impairment (MCI) and early-stage Alzheimer's disease.
You can reach John at https://www.alzheimersrecovery.au/.
The 2022 clinical trial led by Dr Dale Bredesen, which John referred to, is available at https://www.apollohealthco.com/alzheimers-reversal/.
Share this post